Summary: The aim of this study was to define the accuracy of 99 mTc-ethyl cysteinate dimer-single photon emission com puted tomography e 9 mTc-ECD-SPECT) in distinguishing tran sient ischemic attack from completed ischemic stroke at early stages after the onset of symptoms. In a prospective study we examined 82 patients within 6 hours after the onset of symp toms (neurologic deficit caused by middle cerebral artery isch emia) using both 99 mTc-ECD-SPECT and computed tomogra phy (CT). The follow-up was based on Scandinavian Stroke Scale (SSS) 24 hours and 5-7 days, as well as on CT 7 days, after the event. SPECT evaluation was performed both visually and using semiquantitative region-of-interest (ROI) analysis.
hours (hereafter referred to as transient ischemic attack, [TIA] ) to brain death within the following 3 to 5 days ("malignant" middle cerebral artery infarction). About a quarter of all patients who are admitted to hospital with acute focal cerebral ischemia do not need any specific (e.g., thrombolytic) therapy, as they spontaneously re cover (Rothrock et aI., 1995) . Previously, however, it has not been possible to classify symptoms as TIA or minor stroke within the first few hours after the onset of symp toms, either clinically or by using computed tomography (CT). The accuracy of clinical diagnosis on admission ranges from 38% to 89% (von Arbin et aI., 1981; Bam ford, 1992) .
Although acute CT is useful for distinguishing isch emia from intracerebral hemorrhage and other pathologic findings (e.g., brain tumor), it fails to identify ischemia within the first 3 hours after the onset of symptoms, and within a 3-to 6-hour period CT may show indirect signs of evolving infarction in the territory of the middle ce-rebral artery. Within the first 3 to 6 hours after cerebral ischemia, CT has a mean sensitivity of 82% for hemi spheric infarcts (von Kummer et aI., 1996) . The use of magnetic resonance imaging (MRI) provided 7% to 20% false-negative results in acute stroke depending on the size of the infarcted area and the field strength (Alberts et aI., 1992) . Mohr et aI. (1995) found no difference in diagnostic accuracy between MRI and CT within the first 4 hours after the onset of symptoms. Data of large pro spective studies based on more recent MR techniques, such as diffusion-perfusion studies, MR angiography, flow imaging, and spectroscopy, are not yet available, although recent results suggested superiority of diffu sion-perfusion MRI (Warach et aI., 1996) or MRI with fluid-attenuated inversion recovery (FLAIR) sequences (Brant-Zawadzki et aI., 1996) over conventional MRI in the early diagnosis of evolving cerebral infarction. Pos itron emission tomography (PET) examinations are dif ficult to schedule and have so far been limited to a small number of centers (Baron et aI., 1989; Heiss, 1996; Bak ker and Pauwels, 1997) .
Some of the above questions may be answered by single photon emission computed tomography (SPECT) Masdeu et aI., 1994) . Imme diately after the onset of ischemia, SPECT may show the location, size, and extent of decreased or fully impeded cerebral blood flow (Hanson et aI., 1993; Laloux et aI., 1995; Masdeu and Brass, 1995) . Like routine CT, SPECT scans can be visually analyzed quickly and sim ply; any focal perfusion deficits present can be recog nized, and their size and localization can be described (Alexandrov et aI., 1996a) .
State-of-the-art cameras produce high-quality images within 10 to 20 minutes at a spatial resolution of 7 mm. The sensitivity and specificity of SPECT have been re ported to range from 86% to 98% within the first few hours after infarction (Yeh et aI., 1986; Brass et aI., 1994; Weir et aI., 1997) , albeit with a number of limitations (unblinded interpretation, retrospective analysis, small number of patients; Brass et aI., 1994) . Although the potential benefit of SPECT examinations for clinical tri als and therapy decisions has been emphasized, no pro spective studies on the role of SPECT within 6 hours after the onset of symptoms have so far been reported (Alexandrov et aI., 1996b) .
99 mTc-HMPAO and 99 mTc_ECD are newer radiophar maceuticals for SPECT imaging of local cerebral blood flow (Ell et aI., 1985; Leveille et aI., 1989) . However, previous studies using SPECT for early diagnosis of ce rebral ischemia were exclusively carried out using 99 mTc_HMPAO (Giubilei et aI., 1990; Shimosegawa et aI., 1994; Alexandrov et aI., 1995) . Because 99 mTc_ECD cerebral uptake has been shown to be dependent not only on perfusion but also on the metabolic state of brain tissue (Shishido et aI., 1995; Jacquier-Sarlin et aI., 1996) ,
the objective of the present study was to test the useful ness of 99 mTc-ECD-SPECT for the acute diagnosis of cerebral ischemia in the territory of the middle cerebral artery. The particular question was whether it is possible to distinguish patients with transient cerebral ischemia from those with completed infarction within the first 6 hours after the onset of symptoms.
PATIENTS AND METHODS
Between January 1996 and April 1997 227 patients with ischemic stroke were admitted to our Neuro Critical Care Unit. From this cohort, 82 patients (53 men, 29 women) who met the following inclusion and exclusion criteria were enrolled in this prospective study. Inclusion criteria were age 18 to 80 years; sudden onset of a focal neurologic deficit in the territory of the middle cerebral artery (MCA); first stroke; a Scandinavian Stroke Scale (SSS) at the time of injection of 99 mTc_ECD be low 40 points; and SPECT examination within 6 hours after the onset of symptoms. Exclusion criteria were coma; rapid im provement of the symptoms by the time of SPECT examina tion; abnormal CT not consistent with focal ischemia in the MCA territory (e.g., intracerebral hemorrhage, vascular en cephalopathy); vertebrobasilar stroke. Patients were treated af ter early CT and SPECT imaging. Sixty-eight patients received solely heparin intravenously as a means of early secondary prevention (doubling of the partial thromboplastin time) for at least 24 hours, and generally until the safe exclusion of a car diac embolism source. The last 14 patients were part of an ongoing double-blinded, placebo-controlled trial and were treated randomly with recombinant tissue plasminogen activa tor or placebo. The study was approved by the local ethics committee.
mTc-ECD-SPECT
Resting patients with their eyes open were injected with 400 MBq 99 mTc_ethyl cysteinate dimer (ECD) in a quiet, dimly lit room. After injection of the radiopharmaceutical, the subjects were kept in the same condition for an additional 5-minute period. Imaging was begun 10 to 15 minutes after the injection. Photons were registered using a brain-dedicated SPECT cam era (Ceraspect, DSI, Walham, MA, U.S.A.) with three rotating parallel hole-collimators. The spatial resolution obtained with the system is about 7 mm. Within 20 minutes (360° rotation, 120 projections) I to 1.5 million counts were collected in a 128 x 128 x 64 matrix. The data were reconstructed by standard filtered back-projection using a two-dimensional Butterworth filter (cutoff 0.95, order 10). Images were corrected for attenu ation by Chang's first-order method (attenuation coefficient, f1 = 0.15 cm-1). For reorientation the transversal slices were inclined 15° to the canthomeatal line, corresponding to Talair ach and Tournoux's stereotactic system of coordinates (Talair ach and Tournoux, 1988) . The addition of four contiguous slices each resulted in a slice thickness of 6.8 mm (correspond ing to the system's spatial resolution).
The SPECT data were analyzed (1) visually and (2) semi quantitatively using region of interest (ROI) analysis.
Visual analysis. Tomograms were visually analyzed (H.B., S.H., J.B.) immediately after activity registration. This analysis was based on brain slices in three plane orientations (coronal, sagittal, transversal) . Images were classified as showing either symmetrical tracer uptake or focal deficits in an area corre sponding to the neurologic deficit. The investigators were aware of the lateralization of the neurologic deficit, but were not aware of the degree of the clinical symptoms (Scandinavian Stroke Scale) on admission or on day 7.
Semiquantitative ROJ analysis. For semiquantitative ROI analysis, S transversal and 3 coronal slices were selected at predefined distances from the commissura anterior to commis sura posterior (CA-CP) line (transversal slices: Talairach co ordinates = -20 mm, +1 mm, +8 mm, +21 mm, +34 mm) and from the line perpendicular to the aforementioned CA-CP line cutting the commissura anterior (coronal slices: Talairach co ordinates = +S mm, -16 mm, -37 mm), respectively. In these 8 slices, 88 ROI were generated using a commercial program (Cerespect, DSI) and were assigned to anatomic structures us ing the stereotactic atlas (Talairach and Tournoux, 1988) . Count densities of ROI of the symptomatic hemisphere were related to those of the corresponding contralateral regions and classified as "abnormal" if a deficit exceeded 10% (ratio ""0.90) in agreement with widely accepted standards (Podreka et aI., 1987; Hanson et aI., 1993) . In line with Hanson et a1. (1993) , we also used the "SPECT graded scale" -a measure of the intensity and spatial extent of activity deficits. Each ROI was given a score of 0 to 9, where 0 indicated a ratio ?0.91; 1 a ratio of 0.81 to 0.9 (corresponding to 81% to 90% activity compared with the contralateral side); 2 a ratio of 0.71 to 0.8, and so forth. The scores for all individual ROI were added up to produce the SPECT graded scale.
Computed tomography
Nonenhanced cranial CT scans were obtained (Siemens, So matom Plus S, Erlangen, Germany) immediately after admis sion within 6 hours of the onset of symptoms. Slice thickness was S mm. A second CT scan was carried out after 24 to 36 hours, and a third after 7 ± 2 days. Patients with normal second CT and no neurologic deficits after 24 hours did not undergo third CT.
Clinical investigations and follow-up
The Scandinavian Stroke Scale (46 points maximum; with out "gait") was determined immediately before the injection of 99 mTc_ECD, 24 ± 2 hours after the onset of symptoms, and after 7 ± 1 days. Two groups were formed: patients with spontaneous full recovery (SSS = 46 points) within 24 hours (by definition classified as TIA) or 7 days (PRIND, prolonged reversible ischemic neurologic deficit) (according to the National Institute of Neurological Disorders and Stroke; 1990), and patients with sustained neurologic deficit (SSS < 46 points) after 7 days.
Statistical analysis
Clinical data and SPECT findings of both groups were com pared using the Mann-Whitney U test, as well as Student's t test for unpaired data with the level of significance at O.OS. Intraob server variability of visual SPECT analysis was calculated us ing the Kendall-W test after repeated analysis of 40 studies. Interobserver variability of visual analysis was calculated using Kendall-W test after comparing the scores of the three inde pendent observers. Relative risk of cerebral infarction was cal culated for visual SPECT analysis, quantitative SPECT analy sis (number of abnormal ROI, maximal activity ratio, and SPECT graded scale), and SSS on admission after defining cutoff values for the parameters with help of corresponding scatter plots. To identify independent parameters for differen tiation between TIA or PRIND and completed infarction, lo gistic regression was performed by stepwise forward selection of variables with Wald's test using the statistical software SPSS.
RESULTS

Clinical and computed tomography findings
The patients' average age was 63 ± 11 years, and the mean Scandinavian Stroke Scale on admission was 31 ± 8 points (10 to 39 points). In 38 of 82 patients baseline CT showed early signs of infarction.
After 24 hours, 16 patients had no symptoms (indicat ing TIA). Another 7 patients were free of symptoms after 7 days (indicating PRIND). The remaining 59 patients displayed neurologic deficits after 7 days with a mean SSS of 28 ± 12 (0 to 43) points. In all 59 patients CT exhibited ischemic infarctions in the territory of the MCA on day 1 and day 7. Of the 23 patients with TIA or PRIND, however, only 1 patient had a CT showing a lacunar infarction.
The SSS recorded on admission was revealed to be lower in patients who later evolved completed infarction than in those with TIA or PRIND, on average (Table 1 ). All patients with TIA or PRIND had an SSS of more than 30 points on admission. In the group with infarction, however, 30 patients had an SSS of more than 30 points as well (Fig. 1) . In only 16 of these 30 patients did the CT show early signs of infarction.
SPECT findings
All 82 patients who were enrolled in this study had technically successful SPECT scans. In case of patient movement, scanning was briefly stopped and restarted to avoid artifacts. SPECT examinations were carried out 5 ± 2 (l to 6) hours after onset of symptoms on average. In 59 of 82 patients visual analysis revealed focal activity deficits in the territory of the MCA consistent with the clinical symptoms. In all 59 patients with focal activity deficit, this deficit sustained in the MCA territory and was paralleled by CT signs of MCA infarctions as well as by neurologic deficits (SSS <46 points) after 7 days (Fig.  2) . Of the 23 patients with no visible activity deficit, only 1 patient developed a lacunar infarction. All 23 patients were symptom-free after 7 days. Interobserver variability of the visual SPECT analysis equaled 2.0% (w = 0.97, P < 0.00 1); intraobserver variability of the visual scoring (n = 40) equaled 3.4% (w = 0.95, P = 0.003). Table 2 shows the relative risk values (95% confidence intervals) for completed infarction regarding age, sex, SSS on ad mission, and the above SPECT parameters. Logistic re gression was performed to identify parameters that were independently able to predict cerebral infarction. Apart from visual and quantitative SPECT analysis, only SSS on admission had significant predictive value for com pleted infarction. In all patients computer-based SPECT analysis showed abnormal count densities in ROI corresponding with the individual neurologic deficits. Comparing both groups the number of abnormal ROI and the largest num ber of abnormal ROI per activity ratio were significantly different ( Table 1 ).
All patients with transient ischemia had count densi ties in the respective ROI of more than 70%, whereas all patients with subsequent completed infarction had values less than 70% (Fig. 3) . Only one patient in the TIA or PRIND group had a abnormal ROI with an activity level of 3 (corresponding to 61 % to 70% activity). This patient later showed in CT a lacunar infarction.
The average SPECT graded scale calculated was more than 5 times higher in the group of completed infarction than in the TIA or PRIND group (69 versus 13). Fifty five of 59 patients with completed infarction and only 2 of 23 patients with TIA or PRIND had a SPECT graded scale exceeding 20. When comparing the SPECT find ings of 30 patients with completed stroke who, like the patients with TIA or PRIND, had on admission an SSS of more than 30 points, equally clear division was apparent between the two groups in all SPECT parameters exam ined ( Table 1) .
Fourteen of the 82 patients were part of an ongoing double-blind trial with recombinant tissue plasminogen activator. Of these 14 patients, 4 had transient ischemia, whereas 10 suffered completed stroke. All 4 patients with transient ischemia had no visible activity deficit in SPECT examination and count densities in the respective ROI of more than 70%. To discount the possible effect of thrombolytic therapy, we reanalyzed our data without this subgroup of 14 patients. The analysis of 68 patients (Table 3) who had not undergone possible thrombolytic therapy exhibited the same clinical, CT, and SPECT findings when comparing patients with transient isch emia and completed stroke with the entire group of 82 patients.
DISCUSSION
This prospective study was designed to define the ac curacy of SPECT in the differentiation between transient ischemia and evolving cerebral infarction within the ter- ritory of the MCA as early as 6 hours or less after onset of symptoms. All patients in the study were recruited in agreement with the inclusion and exclusion criteria used for the ECASS-l study (Hacke et aI., 1995) and other stroke trials using the same time-window of 6 hours. At the time of SPECT imaging, all patients had moderate to severe neurologic deficits (SSS <40 points). On average, patients evolving completed infarction had significantly less points on the SSS than those with TIA or PRIND. The range of scores of the first group, however, was extremely large. Therefore, about every second patient who developed completed infarction had an SSS score within the range of TIA or PRIND patients, i.e., more than 30 points. Because about 2 of 3 patients enrolled in the study by using the above criteria had SSS more than 30 points, the same proportion of individuals who were candidates for thrombolysis were not able to be classified regarding their prognosis using clinical scales. Within the same early period after the onset of symptoms, the presence of early infarction signs on CT was always predictive of completed stroke. In more than 50% of the patients such signs were absent. The absence of early infarction signs, however, had no predictive value for TIA or PRIND or completed infarction. Visual interpretation of 99 mTc-ECD-SPECT separated these two groups within the first 6 hours after the onset of symptoms. In all patients with activity deficits, CT after a delay of 5 days showed infarction, whereas all patients without visible activity deficit had transient isch emia without subsequent lesions evidenced by CT.
One of the aims of this study was to establish criteria for the above classification, which required quantitative image assessment. Using ROI analysis we found that even the group of patients with TIA or PRIND had ab normalities in their cortical activity distribution. Using an activity threshold of 70% (referring to the activity of the contralateral region as lOO%), however, group sepa ration was as effective as by visual interpretation. This corresponds to the results of a study by Bogousslavsky et ai. (1990) , who pointed out that a reduction in cerebral blood flow of more than 30% within a few days after the onset of neurologic deficits was likely to be associated with subsequent infarction.
Whereas in our study the extent of activity deficits alone (number of abnormal ROJ) was not predictive for the subsequent outcome, the SPECT graded scale as a combination of the size and the severity of activity was found to be an excellent discriminator between the two groups.
Comparing the results of this present study with stud ies previously published is difficult owing to the differ ences in the study design and tracers used. A study on a group of patients of similar size and using SPECT within the same short time-window after onset of neurologic deficits has not yet been reported. Alexandrov et ai. (1995) examined 18 patients with stroke and 12 patients with TIA using 99 mTc-HMPAO-SPECT. However, only 4 of these 12 patients still had clinical symptoms at the time of examination. In combination with trans cranial Doppler sonography, they correctly prognosticated 10 of 12 patients with TIA or minor stroke. Of 31 patients with focal cerebral ischemia, Shimosegawa et ai. (1994) ob served 5 patients without a visible activity deficit in 99 mTc-HMPAO-SPECT who did not develop stroke ac cording to CT or clinical outcome. Reversible and irre versible structural brain damage in their series was sepa rated when a threshold of 40% activity reduction was used compared with the healthy side. Giubilei et al. (1990) examined 32 patients within 6 hours with 99 mTc_ HMPAO-SPECT. All patients with an asymmetry index (affected versus contralateral area) of less than 60% had a poor prognosis; patients with an asymmetry index of more than 60% had a good outcome. After 6 hours, the prognostic value of 99 mTc-HMPAO-SPECT deteriorated owing to postischemic hyperemia (absolute or relative lUXury perfusion) (Lassen, 1966; Raynaud et a!., 1989) . Hartmann (1985) examined 20 patients with TIA us ing the 133 Xe inhalation technique. In 14 patients re gional CBF was determined during the presentation of clinical symptoms. He found a significantly reduced mean CBF in the affected hemisphere compared with the contralateral side and with a control group with a similar risk profile. The flow in affected areas was on average reduced by 25.1% ± 11.7%. However, all CBF levels were above the level where electrical function is af fected, and none of the patients developed an infarction according to follow-up CT. Three of the 20 patients with TIA had arteriosclerosis with narrowing and 2 of the 20 patients had occlusion of the internal carotid artery. Of our 23 patients with TIA or PRIND, 1 patient had oc clusion and 2 patients had hemodynamically relevant ste noses of the internal carotid artery. We found no visible activity deficit in these patients either. This contrasts with Laloux et a!. (1996) , who in 3 of 8 patients with severe carotid artery occlusive lesions in the 99 mTc_ HMP AO-SPECT performed within a mean time interval of 18 hours and 4 days after TIA found a persistent perfusion defect. One reason for this could be the differ ent tracers, although 99 mTc_HMPAO better reflects the perfusion, so that in patients with carotid artery occlusive disease a chronic regional hemodynamic insufficiency could be the cause of persisting hypoperfusion. How ever, the collateral flow is sufficient to protect the brain tissue from infarction, but not to restore normal regional CBF. Examination with 99 mTc_ECD, which probably better reflects the metabolic status of the brain tissue, ought therefore (as was to be seen in our patients) not to highlight perfusion deficits as the brain tissue is intact.
Using PET examinations, Marchal et al. (1996) showed that cerebral areas with early postischemic hyperperfusion and low oxygen extraction fraction (OEF) were able to recover. In the hyperperfused areas the CMRo2 was preserved or even significantly increased, reflecting stimulation of protein synthesis and protein phosphorylation, which is associated with tissue viabil ity. The cause of hyperperfusion was assumed to be the reperfusion of a prior penumbra, a mechanism which Baird et ai. (1995) showed to be "spectacular shrinking deficit" using SPECT. By contrast, ischemic penumbral tissue was characterized by a very high OEF, low CMRo2, and a low CBF. However, the ultimately in farcted penumbra showed in contrast to the subsequently recovered penumbra lower CBF and CMRo2 values, in dicating that reperfusion occurred too late or that irre versible tissue damage had already set in .
Against this pathophysiologic background it is appar ent that merely distinguishing between TIA and PRIND or RRIND (rapid reversible ischemic neurologic deficit) is insignificant. This type of temporal classification is per se retrospective and not pathophysiologically orientated, and ought therefore to be ignored.
Different from the studies quoted dealing with acute SPECT in cerebral ischemia, in this present study 99 rnTc_ ECD was administered instead of 99 mTc_HMPAO. Though both agents represent the new generation of ra diopharmaceuticals for local cerebral blood flow imag ing with SPECT (Holman et a!., 1989; Leveille et aI., 1992; Walovitch et a!., 1991) , 99 mTc_ECD cerebral up take has been evidenced to be codetermined by the meta bolic status of brain tissue. Shishido et a!. (1995) re ported that 99 mTc_ECD uptake was correlated to the ce rebral metabolic rate of oxygen (CMRo2) as determined with PET and that the correlation between 99 mTc_ECD uptake and CBF was less significant. The results of Shishido et a!. are paralleled by those of a combined SPECT and PET study by Ishizu et ai. (1996) . Jacquier Sarlin et a!. (1996) pointed out that the presence of cy tosolic esterase, which is related with viability of cells, is essential for the retention of 99 mTc_ECD in brain tissue. Because of this causality, luxury perfusion obviously does not increase 99 mTc_ECD uptake, whereas increased 99 mTc_HMPAO uptake reflects local blood flow. There fore, disintegration of brain tissue may remain undiscov ered with 99 mTc-HMPAO, whereas 99 mTc_ECD has been suggested to reveal the degree of brain lesions by com promised activity retention (Nakagawara et a!., 1994; Lassen and Sperling, 1994; Devous, 1995) . Accordingly, in none of the patients of this present study was local 99 mTc_ECD activity increased within a brain area corre sponding to the neurologic deficit. This result obtained in a relatively large number of patients lends further sup port to the suggestion that evolving cerebral infarction may not be masked by luxury perfusion when 99 mTc_ ECD is used.
Precisely what therapeutic implications the findings of our study could have currently remain open. If (as ap pears to be the case) 99 mTc_ECD reflects not so much perfusion as metabolism, it is probably not the ideal tracer for screening patients for thrombolytic therapy as this aims to improve perfusion. Moreover, the question must be asked whether a visible activity deficit is always an expression of tissue necrosis and thus whether these patients are even to be excluded from thrombolytic therapy. The few patients included in our study who received thrombolytic therapy "blind" for us showed no difference from the other patients. Moreover, in none of our patients did we observe a correlative for the' 'spec tacular shrinking deficit" as described by Baird et al. (1995) concerning some of their patients. Only a study with a larger number of patients treated with thromboly sis accompanied by fo llow-up examinations with 99 mTc_ ECD-SPECT will be able to definitively answer these questions.
In conclusion, brain SPECT with 99 mTc_ECD within a short time interval after the onset of neurologic deficits is extremely accurate in differentiating between TIA or PRIND and evolving completed infarction. This exami nation is rapid and can be assessed on a visual interpre tation basis as well as using quantitative criteria of re gional activity uptake. Its proper place in the acute stroke protocol is immediately after CT (to exclude cerebral hemorrhage). Performed less than 6 hours after onset of symptoms it may have an impact on patient manage ment-and possibly also on the decision to apply spe cific stroke therapies, e.g., thrombolysis.
